Companion Animal Drug Market

Companion Animal Drugs Market: Private Label OTC Products Mark the Prominent Trend: Global Industry Analysis, 2014 - 2018 and Opportunity Assessment, 2019 - 2029

  • 2019-10-09
  • REP-GB-1077
  • 24 Tables
  • 79 Figures
  • 167 pages
  • PDF PPT EXCEL
 Companion Animal Drug Market

An Incisive, In-depth Analysis on the Companion Animal Drug Market

This study offers a comprehensive, 360 degree analysis on the Companion Animal Drug market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Companion Animal Drug market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

COVID -19 : Impact Analysis

Request the coronavirus imapact analysis across industries and markets

Request Covid -19 Impact

Companion Animal Drugs Market - Key Research Findings

  1. The global companion animal drugs market value in 2019 is estimated at ~ US$ 32
  2. The companion animal drugs market is anticipated to grow at a CAGR of ~ 5% during the forecast period of 2019-2029. 
  3. Parasiticides are expected to remain the most preferred product, accounting for one third share of the companion animal drugs market.
    • The growth in demand for parasiticides is primarily attributed to their effectiveness in protecting the pets against parasites, fleas, ticks, and even mosquitoes.
  4. North America is expected to account for ~ 32% of the revenue shares in the companion animal drugs market by the end of 2029.
    • North America continues to offer greater opportunities, due to presence of market players in the region along with increasing obesity rate among pets in the U.S. 
  5. Growing adoption of companion animal drugs in veterinary clinics in the animal healthcare industry is likely to result in increased market share during the forecast period.
    • Increased demand for proper treatment of pets has led to significant growth in number of veterinary clinics, thereby potentially raising the demand for companion animal drugs.
    • Development of new veterinary vaccines and medications for pets are contributing to the companion animal drugs market growth.

Key Factors Shaping the Companion Animal Drugs Market

  • Increasing Rate of Pet Obesity

    Growing tendency to overfeed pets leads to increasing obesity in pets, globally. This has been negatively impacting the health of pets, thus making them susceptible to more diseases, which in turn, is likely to fuel the demand for companion animal drugs.

    According to the report of Association for Pet Obesity Prevention (APOP) in 2018, it was estimated that 59.5% of cats and 55.8% of dogs were overweight or obese. This is a serious concern and is creating serious health problems in pets. It was also reported that the pets’ owners and veterinarians were often confused by conflicting dietary advice and thus struggle to help pets achieve safe and ideal weights. This increasing obesity among animals is leading to robust growth of the companion animal drugs market.

  • Emergence of New Technologies, Especially in Biologics

    Emergence of new technologies, especially in biologics, such as recombinant DNA vaccines for dogs are expected to eventually drive the demand for specialties in veterinary medicines. Recombinant vaccines provide advanced protection to pet animals. Example of one such vaccine is Recombitek from Sanofi – usually administered to offer broad range protection in canines. Additionally, popularity of compounded drugs has been growing rapidly, due to need for easy access to services and affordable veterinary drugs. Thus, the increasing inclination towards new technologies is projected to fuel the growth of the companion animal drugs market over the forecast period.

  • Growing Prominence of Online Veterinary Pharmacies

    The distribution pattern of veterinary medicines is undergoing a change due to rapid internet penetration across the globe. The number of online veterinary pharmacies has been increasing, as pet owners tend to study disease symptoms online and request for OTC medicines via internet. The trend is more common in the U.S. and the European countries, due to wide availability of online catalogs for prescription drugs. Certain compounding pharmacies also deliver veterinary drugs after receiving an online order. The drugs are ready to be picked up from the store or may also be delivered at the doorstep in some cases.  Thus, the online availability of companion animal drugs are expected to create new opportunities and scope for stakeholders to gain competitive edge in the companion animal drugs market.

Companion Animal Drugs Market Structure Analysis

  • The global companion animal drugs market is a moderately competitive market. Zoetis, Inc, Elanco (Eli Lily), Merck & Co., Inc., and Merial (Boehringer Ingelheim) are the key players contributing maximum revenue share to the market.
  • Expansion of the business through mergers, acquisitions, collaborations, and alliances are the strategies followed by key players in the companion animal drugs market. Key market players focus on strategies such as development of new medications and introducing them into the market for evolving infectious diseases.
  • Noteworthy investments in the research and development for novel drugs are projected to boost the growth prospects of the companion animal drugs market.
  • Global and local market players are benefiting from a significant marketing network of distributors. Also, online veterinary pharmacy services are contributing to the growth of the companion animal drugs market.

Companion Animal Drugs Market Analysis 2019-2029

A recent market study published by Future Market Insights on the companion animal drugs market includes global industry analysis 2014-2018 & opportunity assessment 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the companion animal drugs market, the growth prospects of the market are obtained with maximum precision.

Companion Animal Drugs Market: Segmentation

The global companion animal drugs market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

Distribution channel

Region

  • Antibiotics

  • Anti-inflammatory

  • Parasiticides

  • Heart Worm Products

  • Behavioral Products

  • Nutritional Products

  • Skin Care Products

  • Vaccines

  • Veterinary Hospitals

  • Veterinary Clinics

  • Pharmacies and Drug Stores

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • APEJ

  • Japan

  • Middle East and Africa

Report Chapters

Chapter 01 – Executive Summary

The report initiates with the executive summary of the companion animal drugs market, which includes a summary of key findings and statistics of the market. It also includes drivers and trends pertaining to the companion animal drugs market.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the companion animal drugs market in this chapter, which will help them understand the basic information about the companion animal drugs market. Along with this, comprehensive information pertaining to companion animal drugs and their properties are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the companion animal drugs market report.

Chapter 03 – Market Dynamics

This section gives information about drivers, and restraints of the companion animal drugs market. This section also includes various opportunities and key trends of the companion animal drugs market.

Chapter 04 – Market Context

This section gives information about upcoming pipeline products, PEST analysis, Porter’s Five Forces Model, and regulatory scenario of the companion animal drugs market.

Chapter 05 – Global Companion Animal Drugs Market Demand Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section explains the global market value analysis and forecast for the companion animal drugs market in the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical companion animal drugs market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Product Type

Based on the product type, the companion animal drugs market is segmented into antibiotics, anti-inflammatory, parasiticides, heart worm products, behavioral products, nutritional products, skin care products and vaccines. In this chapter, readers can find information about the key trends and developments in the companion animal drugs market and market attractiveness analysis based on the type.

Chapter 07 – Global Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Distribution Channel

This chapter provides details about the companion animal drugs market based on the distribution channel, and has been classified into veterinary hospitals, veterinary clinics and pharmacies and drug stores. In this chapter, readers can understand the market attractive analysis based on the distribution channel.

Chapter 08 – Global Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region

This chapter explains how the companion animal drugs market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa (MEA).

Chapter 09 – North America Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter includes a detailed analysis of the growth of the North America companion animal drugs market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the product type, distribution channel, and countries in North America.

Chapter 10 – Latin America Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of the companion animal drugs market in Latin American countries such as Brazil, Mexico, Argentina, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 11 – Western Europe Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the companion animal drugs market based on its end users in several countries such as the U.K., France, Germany, Spain, Italy, Nordics, Benelux and the Rest of Western Europe are included in this chapter.

Chapter 12 – Eastern Europe Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the companion animal drugs market based on its end users in several countries such as the Russia, Poland and the Rest of Eastern Europe are included in this chapter.

Chapter 13 – Asia Pacific excluding Japan (APEJ)  Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

In this chapter, China, India, Australia and New Zealand, ASEAN and Rest of Asia Pacific countries are the prominent countries in the Asia Pacific excluding Japan region that are the prime subjects of assessment to obtain the growth prospects of the APEJ companion animal drugs market. Readers can find detailed information about the growth parameters of the APEJ companion animal drugs market during the forecast period of 2019-2029.

Chapter 14 – Japan Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section highlights the growth prospects of the companion animal drugs market for Japan, during the forecast period of 2019-2029

Chapter 15 – MEA Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides information about how the companion animal drugs market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019-2029.

Chapter 16 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the companion animal drugs market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Elanco (Eli Lilly), Zoetis, Inc., Merck & Co., Inc, Merial (Boehringer Ingelheim), Sanofi, Bayer AH, Vibrac SA, and Ceva Sante.

Chapter 17 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the companion animal drugs market report.

Chapter 18 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the companion animal drugs market.

Industry Interactions

  • C - Level Executives

  • Marketing Directors

  • Product Managers 

  • Business Development Officers 

  • Production Managers

  • Procurement Heads

  • Sales Executives

  • Distributors

  • Traders 

  • Raw Material Suppliers

  • Industry Experts

  • End Users

  • Current market dynamics and challenges

  • Yesteryear trends 

  • Market characteristics

  • Market performance and growth quadrants

  • Competition structure and market structure

  • Strategic growth initiatives

  • Near-term and long-term market growth prospects

  • Market segment splits and authenticity

  • Opinions on market projections and validity of assumptions

Primary Interview Splits global companion animal drugs market designations

References Catalogue

  • Industry Publications

  • The Veterinary Journal

  • Journal of Veterinary Science

  • Pet Companion Magazine

  • Industry Associations

  • American Veterinary Medical Association

  • The Association for Pet Obesity Prevention

  • The European Pet Organization

  • The American Pet Association

  • Factiva

  • Company Press Releases

  • Annual Reports and Investor Presentations

  • Research Papers

  • Government Websites and Publications

  • Trade Websites

Primary Interview Splits global companion animal drugs market stakeholders

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology